Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children

This study has been completed.
Sponsor:
Collaborators:
Institut de Recherche pour le Developpement, Senegal
Institut de Recherche pour le Developpement
Cheikh Anta Diop University, Senegal
Ministry of Health, Senegal
Information provided by (Responsible Party):
Brian Greenwood, London School of Hygiene and Tropical Medicine
ClinicalTrials.gov Identifier:
NCT00132561
First received: August 18, 2005
Last updated: January 11, 2017
Last verified: January 2017